Asston Pharmaceuticals bulk deals and stake changes
BSE: 544445Pharmaceuticals & BiotechnologySmall Cap
Last close ₹129.79up ₹5.85 (4.72%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹123.94.
52-week range of traded prices to 23 Oct 2026
₹60.00Low, 21 Jul 2026₹130.13High, 23 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹142 Cr3,188th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 29 May 2026
- 274.2
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.35 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 36.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 29 May 2026
- 1.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹3.35 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 9.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 29 May 2026
- −2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,19,000
Asston Pharmaceuticals stake sales and purchases
All 3 disclosures on record.
Sep 2026
- AcquiredPrakruti R Pali1.77% of the company1,51,000 sharesholds 9.03% after1 Sep 2026 · filed under the 2% rule · Market
Aug 2026
- AcquiredPrakruti R Pali1.93% of the company1,64,000 sharesholds 7.26% after28 Aug 2026 · filed under the 2% rule · Market
- AcquiredPrakruti R Pali2.82% of the company2,40,000 sharesholds 5.33% after27 Aug 2026 · filed under the 5% rule · Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Asston Pharmaceuticals bulk deals
Last 12 months, since 23 Oct 2025: 13 bulk deals, ₹9.77 Cr bought and ₹2.51 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Friday 23 Oct 20261 firm · ₹0.59 Cr bought · ₹0 soldNet bought ₹0.59 Cr
- BoughtPRASHANT P SAWANTBought 46,000 at ₹129.160.42% of the company₹0.59 Cr
Tuesday 1 Sep 20261 firm · ₹0.63 Cr bought · ₹0 soldNet bought ₹0.63 Cr
- BoughtPRAKRUTI R PALIBought 51,000 at ₹123.040.60% of the company₹0.63 Cr
Monday 31 Aug 20262 firms · ₹1.75 Cr bought · ₹0 soldNet bought ₹1.75 Cr
- BoughtPRAKRUTI R PALIBought 1,00,000 at ₹123.881.17% of the company₹1.24 Cr
- BoughtSNEHLATA MANOJ KATHOTIABought 43,000 at ₹119.100.51% of the company₹0.51 Cr
Friday 28 Aug 20261 firm · ₹1.85 Cr bought · ₹0 soldNet bought ₹1.85 Cr
- BoughtPRAKRUTI R PALIBought 1,64,000 at ₹112.811.93% of the company₹1.85 Cr
Thursday 27 Aug 20261 firm · ₹2.49 Cr bought · ₹0 soldNet bought ₹2.49 Cr
- BoughtPRAKRUTI R PALIBought 2,40,000 at ₹103.692.82% of the company₹2.49 Cr
Wednesday 26 Aug 20261 firm · ₹1.32 Cr bought · ₹0 soldNet bought ₹1.32 Cr
- BoughtPRAKRUTI R PALIBought 1,38,000 at ₹95.591.62% of the company₹1.32 Cr
Thursday 20 Aug 20262 firms · ₹0.55 Cr bought · ₹0.57 Cr soldNet sold ₹0.02 Cr
- SoldVANITA ANILKUMAR KUMBHARESold 70,000 at ₹81.040.82% of the company₹0.57 Cr
- BoughtSNEHLATA MANOJ KATHOTIABought 67,000 at ₹81.680.79% of the company₹0.55 Cr
Friday 17 Jul 20261 firm · ₹0 bought · ₹0.67 Cr soldNet sold ₹0.67 Cr
- SoldDILIP RAMESHCHANDRA JAGADSold 1,00,000 at ₹66.551.17% of the company₹0.67 Cr
Friday 12 Jun 20262 firms · ₹0.59 Cr bought · ₹0.86 Cr soldNet sold ₹0.27 Cr
- SoldMINERVA VENTURES FUNDSold 1,34,000 at ₹64.051.57% of the company₹0.86 Cr
- BoughtPRAKRUTI R PALIBought 75,000 at ₹78.410.88% of the company₹0.59 Cr
Thursday 1 Jan 20261 firm · ₹0 bought · ₹0.42 Cr soldNet sold ₹0.42 Cr
- SoldKINGSMAN WEALTH FUND PCC - KIF IISold 50,000 at ₹84.120.59% of the company₹0.42 Cr
Monday 28 Jul 20251 firm · ₹0 bought · ₹0.64 Cr soldNet sold ₹0.64 Cr
- SoldJSK SECURITIES AND SERVICES PRIVATE LIMITEDSold 52,000 at ₹123.37₹0.64 Cr
Monday 21 Jul 20251 firm · ₹0 bought · ₹0.53 Cr soldNet sold ₹0.53 Cr
- SoldPRADIP BISHANDAS PANJABISold 45,000 at ₹117.67₹0.53 Cr
Friday 18 Jul 20251 firm · ₹0 bought · ₹0.60 Cr soldNet sold ₹0.60 Cr
- SoldNEHA MISHRASold 50,000 at ₹119.66₹0.60 Cr
Wednesday 16 Jul 20254 firms · ₹3.71 Cr bought · ₹0 soldNet bought ₹3.71 Cr
- BoughtMAHESH VISHNUPANT MULAYBought 1,57,000 at ₹118.91₹1.87 Cr
- BoughtAMIT RAJENDRA PRASAD AGARWALBought 59,000 at ₹119.00₹0.70 Cr
- BoughtNEHA MISHRABought 50,000 at ₹119.12₹0.60 Cr
- BoughtPRADIP BISHANDAS PANJABIBought 45,000 at ₹122.01₹0.55 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 21 deals on record since listing on 16 Jul 2025.